Beauty Health Co

Beauty Health Co

SKIN · NASDAQ · Consumer Defensive / Household & Personal Products

16.31USD+0.35 (+2.19%)

Price History

Full chart

Market Stats

Previous Close15.96
Open15.75
Day Range15.27 – 16.64
52-Week Range0.551 – 1.98
Volume86.31K
Market Cap86.52M
P/E (TTM)0.00
Forward P/E25.51
EPS-0.23
Dividend Yield0.00%
Beta1.00
50-Day Avg0.6913
200-Day Avg0.9522

About

SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.

Company Details

  • SectorConsumer Defensive
  • IndustryHousehold & Personal Products
  • CEOMr. Pedro Malha
  • Employees613
  • Headquarters3600 E. Burnett Street, Long Beach, CA, United States, 90815, USA
  • Websitehttps://www.skinhealthsystems.com

Leadership

  • Mr. Pedro MalhaCEO, President & Director · b. 1972
  • Mr. Michael P. MonahanChief Financial Officer · b. 1972
  • Mr. Paul Bokota J.D.Senior VP & General Counsel
  • Ms. Whitney CypesChief Brand & Clinical Innovation Officer
  • Ms. Tanja WirtzSenior Vice President of International
  • Ms. Kelly PenningtonSenior Vice President of Americas

Financials

Income Statement

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue112.31M166.62M119.09M260.09M365.88M397.99M334.29M300.79M
Growth (%)-+48.36%-28.53%+118.39%+40.68%+8.78%-16.00%-10.02%
Cost of Revenue39.34M60.11M51.89M81.55M117.10M242.88M152.00M104.43M
Gross Profit72.97M106.51M67.20M178.54M248.78M155.11M182.30M196.36M
Gross Margin64.98%63.92%56.43%68.65%68.00%38.97%54.53%65.28%
Operating Expense62.91M93.05M84.38M218.47M274.62M286.03M250.07M217.17M
Operating Income10.06M13.46M-17.18M-39.93M-25.84M-130.92M-67.77M-20.80M
Operating Margin8.96%8.08%-14.43%-15.35%-7.06%-32.89%-20.27%-6.92%
EBITDA21.55M27.89M-2.81M-350.93M81.60M-53.56M10.34M38.74M
EBITDA Margin19.19%16.74%-2.36%-134.93%22.30%-13.46%3.09%12.88%
Net Income-317.00K-1.64M-29.18M-378.76M44.22M-100.12M-29.10M-9.52M
Net Income Margin-0.28%-0.98%-24.50%-145.63%12.09%-25.16%-8.70%-3.16%
R&D2.40M4.61M3.41M8.20M8.44M10.10M6.30M5.63M
R&D as % of Total Revenue2.14%2.77%2.86%3.15%2.31%2.54%1.88%1.87%
Interest Expense10.05M17.09M21.27M11.78M13.39M13.65M10.41M19.33M
Interest Expense % of Total Revenue8.95%10.26%17.86%4.53%3.66%3.43%3.11%6.43%

Balance Sheet

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-226.35M222.84M1.22B1.00B929.11M685.68M499.80M
Total Liabilities-227.56M252.79M916.51M836.03M869.72M633.88M438.70M
Total Equity--1.21M-29.96M302.30M167.05M59.39M51.80M61.10M
Cash-7.31M9.49M901.89M568.20M523.02M370.06M232.70M
Total Debt-190.20M216.54M733.63M751.79M752.29M568.16M378.70M
Net Debt-182.89M207.05M-171.97M183.59M229.26M198.09M146.00M

Cash Flow

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-895.00K1.73M-12.44M-28.36M-106.60M21.75M16.13M37.48M
Investing Cash Flow-8.44M-12.48M-3.82M-37.73M-18.87M-31.51M-6.79M-5.16M
Financing Cash Flow11.16M14.58M18.27M959.03M-205.24M-37.45M-158.34M-174.93M
Capital Expenditure7.88M10.42M3.82M15.62M17.39M13.05M6.79M5.16M
Free Cash Flow-8.78M-8.69M-16.25M-43.98M-123.99M8.70M9.34M32.32M
Dividends Paid98.71M0323.00K-----
FCF to OCF981.01%-503.13%130.69%155.06%116.32%40.00%57.89%86.23%
Dividend Paid to FCF-1124.27%0.00%-1.99%-----

Earnings

Report DateDec 31, 2019Nov 16, 2020Mar 18, 2021May 13, 2021Aug 10, 2021Nov 9, 2021Feb 22, 2022May 10, 2022Aug 9, 2022Nov 8, 2022Feb 28, 2023May 10, 2023Aug 9, 2023Nov 14, 2023Mar 12, 2024May 9, 2024Aug 8, 2024Nov 12, 2024Mar 12, 2025May 8, 2025Aug 7, 2025Nov 5, 2025Mar 18, 2026May 7, 2026Aug 6, 2026Nov 5, 2026
EPS Estimate0.000.00-0.02-0.020.02-0.01-0.020.010.020.020.04-0.020.050.09-0.07-0.070.01-0.04-0.10-0.07-0.06-0.05-0.04-0.01-0.04-0.07
EPS Actual51.72-135.60-0.02-0.060.090.020.01-0.060.010.050.05-0.040.150.050.010.050.080.04-0.080.040.030.03-0.060.03-0.02-
Surprise--0.00%-200.00%350.00%300.00%150.00%-700.00%-50.00%150.00%25.00%-100.00%200.00%-44.44%114.29%171.43%700.00%200.00%20.00%157.14%150.00%160.00%-58.73%400.00%50.00%-
Timing--After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap86.52M
Enterprise Value248.60M
Trailing P/E0.00
Forward P/E25.51
PEG Ratio0.93
Price / Sales0.30
Price / Book1.58
EPS-0.23
Book Value0.427
Revenue (TTM)290.05M
Gross Profit (TTM)192.45M
EBITDA20.08M
Profit Margin-9.80%
Operating Margin4.95%
Return on Equity-43.89%
Return on Assets-0.54%
Shares Outstanding130.14M
Shares Float55.73M
Beta1.00
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Hold
Based on 9 analystsTarget 0.9917
  • Hold
    7
  • Sell
    2

Ownership Breakdown

Institutions
77.18%
Insiders
13.03%
Retail / Other
9.79%

Top Institutional Holders

  • Capricorn Fund Managers Ltd
    22.28M17.12%
  • FMR Inc
    17.18M13.20%
  • Millennium Management LLC
    7.54M5.79%
  • BlackRock Inc
    7.36M5.65%
  • Woodline Partners LP
    5.70M4.38%
  • Vanguard Capital Management, LLC
    3.44M2.64%
  • Geode Capital Management, LLC
    2.24M1.72%
  • State Street Corp
    1.88M1.45%
  • Vanguard Portfolio Management, LLC
    1.65M1.27%
  • Silver Point Capital LP
    1.59M1.22%
  • D. E. Shaw & Co LP
    1.43M1.10%
  • Northern Trust Corp
    809.28K0.62%
  • Charles Schwab Investment Management Inc
    726.01K0.56%
  • Prescott Group Capital Management LLC
    639.18K0.49%
  • Glendon Capital Management LP
    636.95K0.49%
  • The Goldman Sachs Group Inc
    626.88K0.48%
  • Vanguard Fiduciary Trust Co
    586.77K0.45%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    2.48M1.91%
  • Fidelity Growth Company Fund
    1.03M0.79%
  • Silver Point Spe Lend A-1 Debt-CLO
    913.46K0.70%

Stock Splits

  • Oct 14, 20261:20